NYSEAMERICAN:PFNX

Pfenex (PFNX) Stock Price, News & Analysis

Pfenex logo
$12.75 0.00 (0.00%)
As of 10/1/2020

About Pfenex Stock (NYSEAMERICAN:PFNX)

Key Stats

Today's Range
$12.75
▼
$12.75
50-Day Range
$12.75
▼
$12.75
52-Week Range
$5.26
▼
$14.00
Volume
N/A
Average Volume
503,865 shs
Market Capitalization
$437.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pfenex was a biotechnology company that developed recombinant proteins and biosimilar medicines using its Pfenex Expression Technology platform. Its work focused on producing complex proteins for pharmaceutical applications.

The company advanced PF708, a teriparatide injection later marketed as Bonsity, and collaborated with Pfizer on PF-06439535, a bevacizumab biosimilar marketed as Zirabev. These products were developed for markets including the United States and other countries through commercial partnerships.

Based in San Diego, California, Pfenex became part of Ligand Pharmaceuticals after Ligand completed its acquisition of the company in 2020.

AI Generated. May Contain Errors.

Receive PFNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfenex and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PFNX Stock News Headlines

NKY Medical Holdings Ltd Class A 300109
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Headlines

PFNX Stock Analysis - Frequently Asked Questions

Pfenex's stock was trading at $12.75 at the beginning of 2026. Since then, PFNX shares have increased by 0.0% and is now trading at $12.75.

Pfenex Inc. (NYSEAMERICAN:PFNX) released its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.07. The biotechnology company had revenue of $680 thousand for the quarter, compared to analysts' expectations of $3.75 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pfenex investors own include Inovio Pharmaceuticals (INO), Alibaba Group (BABA), Bank of America (BAC), Anheuser-Busch InBev SA/NV (BUD), Salesforce (CRM), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSEAMERICAN:PFNX
Previous Symbol
NYSEMKT:PFNX
CIK
N/A
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,297,000
Free Float
N/A
Market Cap
$437.29 million
Optionable
Not Optionable
Beta
N/A
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSEAMERICAN:PFNX) was last updated on 10/1/2020 by MarketBeat.com Staff.
From Our Partners